Status:
COMPLETED
The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Coronary Disease
Ventricular Dysfunction, Left
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to test whether ivabradine is able to reduce cardiovascular events when given to patients with coronary artery disease and impaired heart function.
Eligibility Criteria
Inclusion
- Coronary artery disease
- Left ventricular systolic dysfunction
- Sinus rhythm: heart rate (HR) \>= 60 beats per minute (bpm)
Exclusion
- Unstable cardiovascular condition
- Severe congestive heart failure
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
10917 Patients enrolled
Trial Details
Trial ID
NCT00143507
Start Date
December 1 2004
End Date
February 1 2008
Last Update
April 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton National Heart and Lung Hospital
London, United Kingdom, SW3 6NP